Language 
More Language
Language Last updated on July 15, 2026 Customer Background
A leading medical imaging technology manufacturer was developing advanced ceramic scintillators to improve light output in next-generation PET/CT detectors. They aimed to achieve consistent scintillation performance while addressing complex challenges related to particle size distribution and impurity levels. The company's pilot line was gearing up for a significant production scale to meet upcoming demands in the healthcare sector.
The customer faced significant issues with scintillator performance due to the variability in light output and sintering defects. Their previous Yb₂O₃ (Ytterbium Oxide) powder source did not meet the stringent 99.9% purity requirement, which led to trace metal contamination. This contamination created absorption centers that quenched scintillation light, compromising the quality of their detectors. In addition, performance metrics were negatively impacted by the failure to control particle size distribution, as particles below 1 micron agglomerated, causing inconsistencies in green-body density, while larger particles over 7 microns resulted in residual pores post-sintering.
The customer reviewed several suppliers, ultimately selecting Stanford Advanced Materials (SAM) due to our robust history in supplying high-purity rare earth materials and our proven capability for batch-to-batch reproducibility in varying volumes.
SAM was able to offer a comprehensive service, including precise impurity fingerprinting via Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and laser diffraction particle size analysis to match their specifications. Furthermore, our commitment to non-contaminated production runs aligned perfectly with their requirements for a reliable supply chain.
SAM supplied high-purity Yb₂O₃ powder with a guaranteed purity of 99.9%, and provided both 1 kg evaluation samples and 20 kg pilot production lots, maintaining identical sieve fractions across batches. This approach facilitated seamless scaling from their initial evaluations to full-scale production. Our ICP-MS reports detailed impurities, detecting elements down to 1 ppm, ensuring the stringent control necessary for development. We further conducted laser diffraction analysis ensuring the median particle size (D50) fell within the critical 2-5 microns range, which is vital for achieving optimal scintillation properties in their application.
With SAM's Yb₂O₃ powder, the customer was able to dramatically reduce scintillation light quenching, achieving a performance stability that satisfied their demanding application standards. The optimized particle size distribution enabled effective slip-casting without agglomeration, maintaining consistent green-body density and eliminating the issue of residual pores post-sintering. Ultimately, the customer's yield improved significantly, leading to enhanced light output uniformity in their ceramic scintillators and reducing production variability.
However, an engineering trade-off was identified during the assessment phases: the fast lead times demanded by the customer meant some batches required rapid production cycles, which put limits on our usual extensive quality assessments. We recommended maintaining 99.9% purity but noted that this might result in slightly delayed initial evaluations compared to immediate availability of lower purity options. Nevertheless, the long-term performance benefits outweighed these constraints.
These enhancements are expected to position the customer competitively in the medical imaging market, paving the way for future innovations in PET/CT technologies.
If you want to further optimize your ceramic processes, take a look at our insights on ceramic processing techniques and dimensional control.
1. High-purity Yb₂O₃ powder is critical for enhancing scintillation properties in medical imaging components.
2. Even minor variances in particle size distribution can lead to significant downstream effects, impacting product performance.
3. SAM's commitment to quality control and customization aligns perfectly with the complex requirements of advanced medical device manufacturing.
4. Effective collaboration with suppliers can resolve performance challenges and lead to breakthrough improvements in product quality.